Method and treatment of recurring endometrial cancer with an inhibitor of USP14
USP14 is a biomarker for recurrent disease and inhibition of USP14 is of therapeutic benefit for women with endometrial or ovarian cancer.
1. A method to selectively treat a subject at risk of recurring endometrial cancer, which comprises selectively administering to the subject an agent which inhibits the activity of USP14, on the basis of said subject having previously been determined to have increased expression of USP14 in said cancer as compared to a control.
2. The method of claim 1 , wherein the agent is a protein, nucleic acid and/or small molecule.
3. The method of claim 2 , wherein the small molecule is VLX1570 or RA-9.
4. The method of claim 1 , further comprising surgery, chemotherapy, and/or radiation.
5. The method of claim 4 , wherein the surgery comprises lymph node dissection.
6. The method of claim 1 , wherein the cancer is chemoresistant.